X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (55) 55
index medicus (42) 42
female (41) 41
diabetes (40) 40
male (40) 40
aged (32) 32
middle aged (32) 32
diabetes mellitus, type 2 - drug therapy (30) 30
risk factors (27) 27
hypoglycemic agents - therapeutic use (26) 26
type 2 diabetes (25) 25
cardiovascular disease (24) 24
abridged index medicus (23) 23
double-blind method (21) 21
diabetes mellitus, type 2 - complications (19) 19
medicine, general & internal (19) 19
cardiac & cardiovascular systems (18) 18
cardiovascular diseases (18) 18
cardiovascular diseases - prevention & control (18) 18
glucose (18) 18
mellitus (17) 17
mortality (17) 17
endocrinology & metabolism (16) 16
incidence (16) 16
diabetes mellitus, type 2 - blood (14) 14
follow-up studies (14) 14
cardiovascular diseases - epidemiology (13) 13
clinical trials (13) 13
diabetes mellitus (13) 13
health risk assessment (13) 13
hypoglycemic agents - administration & dosage (13) 13
prevention (13) 13
risk (13) 13
care and treatment (12) 12
treatment outcome (12) 12
cardiovascular diseases - etiology (11) 11
cardiovascular diseases - mortality (11) 11
disease (11) 11
drug therapy (11) 11
blood pressure (10) 10
dextrose (10) 10
insulin - therapeutic use (10) 10
nateglinide (10) 10
studies (10) 10
blood glucose - metabolism (9) 9
cardiovascular (9) 9
hypertension (9) 9
metaanalysis (9) 9
research (9) 9
heart attacks (8) 8
hypoglycemic agents (8) 8
hypoglycemic agents - adverse effects (8) 8
kaplan-meier estimate (8) 8
proportional hazards models (8) 8
tetrazoles - therapeutic use (8) 8
trial (8) 8
valine - analogs & derivatives (8) 8
valine - therapeutic use (8) 8
valsartan (8) 8
adult (7) 7
cyclohexanes - therapeutic use (7) 7
diabetes therapy (7) 7
drug therapy, combination (7) 7
glucose intolerance - drug therapy (7) 7
heart attack (7) 7
myocardial infarction (7) 7
patient outcomes (7) 7
patients (7) 7
phenylalanine - analogs & derivatives (7) 7
phenylalanine - therapeutic use (7) 7
prevalence (7) 7
research design (7) 7
sitagliptin (7) 7
therapy (7) 7
administration, oral (6) 6
analysis (6) 6
angiotensin ii type 1 receptor blockers - therapeutic use (6) 6
blood glucose - analysis (6) 6
cardiovascular diseases - complications (6) 6
complications (6) 6
diabetes mellitus, type 2 - epidemiology (6) 6
diabetic angiopathies - epidemiology (6) 6
diabetic angiopathies - prevention & control (6) 6
diagnosis (6) 6
evaluation (6) 6
heart-failure (6) 6
niddm (6) 6
outcomes (6) 6
risk-factors (6) 6
united states - epidemiology (6) 6
acarbose (5) 5
aged, 80 and over (5) 5
association (5) 5
body mass index (5) 5
cardiac patients (5) 5
cardiovascular-disease (5) 5
cerebral infarction (5) 5
clinical medicine (5) 5
dosage and administration (5) 5
exercise (5) 5
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2008, 1. Aufl., Contemporary endocrinology, ISBN 1588297942, xiii, 474
As the global epidemic of diabetes continues to expand, the prevalence of type 2 diabetes is predicted to double in the next 20 years. Type 2 Diabetes... 
Evidence-based medicine | Non-insulin-dependent diabetes | Diabetes Mellitus, Type 2 | Clinical & internal medicine | General Practice / Family Medicine | Internal Medicine | Diabetes | Medicine & Public Health | Endocrinology
Book
The New England Journal of Medicine, ISSN 0028-4793, 09/2017, Volume 377, Issue 13, pp. 1228 - 1239
This trial, which compared once-weekly exenatide plus usual care with usual care alone in patients with type 2 diabetes with or without previous cardiovascular... 
MEDICINE, GENERAL & INTERNAL | RISK | EVENT LOWERING EXSCEL | GLUCOSE CONTROL | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Exenatide | Peptides - administration & dosage | Incidence | Cardiovascular Diseases - complications | Hypoglycemic Agents - administration & dosage | Injections, Subcutaneous | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Venoms - administration & dosage | Female | Diabetes Mellitus, Type 2 - complications | Double-Blind Method | Drug Administration Schedule | Venoms - adverse effects | Kaplan-Meier Estimate | Diabetes Mellitus, Type 2 - blood | Least-Squares Analysis | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Peptides - adverse effects | Type 2 diabetes | Usage | Patient outcomes | Outcome and process assessment (Health Care) | Reports | Dosage and administration | Drug therapy | Observations | Myocardial infarction | Cerebral infarction | Diabetes mellitus | Pancreatitis | Amylin | Cardiovascular disease | Patients | Thyroid carcinoma | Studies | Side effects | Pancreatic carcinoma | Pancreatic cancer | Diabetes | Health risk assessment | Heart diseases | Endocrinology | Pharmaceuticals | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 06/2017, Volume 19, Issue 6, pp. 791 - 799
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2015, Volume 373, Issue 3, pp. 232 - 242
Journal Article